Friday, 18 Jan 2019

You are here

Nailfold Videocapillaroscopy in Dermatomyositis

A study of nailfold videocapillaroscopy (NVC) in patients with idiopathic inflammatory myopathies (IIMs) finds abnormalities in more than half of patients suggesting this could be a useful clinical tool in diagnosing and managing patients with IIM. 

A prospective study of 70 consecutive Japanese patients with untreated IIMs included clinical assessments, NVC, serologic studies and skin biopsies of DM rash at baseline and 1 year after of immunosuppressive therapy.

NVC abnormalities were seen in 55.7% of IIM patients, moreso in those with dermatomyositis (DM) (65.4%) compared with polymyositis (27.8%) (P = 0.01).

NVC abnormalities were more common in patients with autoantibodies against anti-MDA5 (87.5%) and anti-transcriptional intermediary factor 1γ (TIF-1γ)  (88.9%) vs anti-aminoacyl-tRNA synthetase (26.9%, P < 0.001).

NVC positive patients had more severe lymphocytic infiltration in the upper dermis on skin rash biopsy in DM patients P < 0.05).

With 1 year of drug therapy, NVC abnormalities disappeared in 75% of IIM patients, which distinguishes them from scleroderma patients whose NVC changes are static.

Add new comment

More Like This

Early Predictive Factors for Scleroderma Renal Crisis

It has been historically said that risk factors for scleroderma renal crisis (SRC) includes include cold exposure, steroid use, dehydration, rapid progression of skin disease, tendon friction rubs, anti-RNA polymerase III antibodies and pregnancy.  A new study examines risk factor for SRC at the onset and diagnosis in systemic sclerosis patients. 

Best of 2018: Ustekinumab May be Effective in Lupus

Ronald F van Vollenhoven and colleagues have reported in Lancet that ustekinumab (UST), an interleukin-12 and -23 inhibitor, when added to usual therapy in systemic lupus erythematosus (SLE) patients, was shown to be superior to placebo at improving clinical efficacy and laboratory parameters after 6 months of therapy.

TIF1-Ab in Dermatomyositis Linked to Higher Cancer Risk

Several epidemiological studies have reported that a diagnosis of DM or PM may be associated with increased cancer risk. The association appears stronger for DM than PM. Based on a meta-analysis, DM cancer risk is five times higher than in the general population and twice that compared with PM cancer risk. 

Genetic Diagnosis for Previously Undiagnosed Disorders

The NEJM has reported the NIH's Undiagnosed Diseases Network (UDN) study results of genetically identifying new diseases from prospectively followed persons with undiagnosed disorders. The UDN was formed in 2014 as a network of seven clinical sites, two sequencing cores, a coordinating center, central biorepository, a metabolomics core, and a model organisms screening center. It was established to apply a multidisciplinary model in the evaluation of the most challenging cases and to identify the biologic characteristics of newly discovered diseases.

SLE and Risk of Malignancy

The risk for cancer in systemic lupus erythematosus (SLE) patients has been inconsistently studied.  A new metanalysis shows that SLE has an increased risk for 16 specific cancers and decreased risk for prostate cancer and cutaneous melanoma.